Asset-based fees (~26% of Index) ride equity-market AUM — a market drawdown hits revenue and the multiple together
One-line thesis. MSCI is a toll-road on global investing — an 82%-gross-margin index-and-analytics franchise with 95% retention and pricing power — but at 34× trailing earnings with growth easing into the high-single digits and the Street's own targets sitting essentially at today's price, there is no margin of safety. A wonderful business at a full price: Watch, buy the dip.
◆ Synthos call — Buy — TacticalMSCI offers ~13% upside to fair value (~$680) with the trend confirming — buy $592–$603, take profits toward $680, and exit on a close below the 200-day (~$569).
Downside Risk (lower = safer)
6/10 · High
Fortress-quality economics but 34× trailing, EV/EBITDA 25×, net-debt/EBITDA ~3.0×, beta 1.23, asset-based fees ride the market.
Growth Quality
8/10 · Very High
~9% fwd revenue / ~13% fwd EPS CAGR, 82% gross & 55% operating margin, 95% retention, wide index moat — but growth is easing.
Exponential Potential
4/10 · Moderate
Toll-road compounder, not an exponential — revenue growth decelerating 11%→6% and a $44B cap with no accelerating second derivative.
◆ Target entry zone$592 – $603accumulate in this band; ideal adds on a dip toward the 50-day average near $592, keeping roughly a 11% margin below our $680 base-case fair value⚖ Reverse-DCF cross-checkMarket-implied growth ≈ 24%/yrTo justify today’s $603, earnings would have to compound roughly 24% a year for 10 years (9% discount rate). Analysts forecast ~11%/yr, so the market is pricing in MORE than what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
MSCI runs the stock-market scoreboards (indexes like MSCI World and MSCI Emerging Markets) that trillions of dollars of ETFs and funds are built on top of, plus the risk-and-analytics software big investors use. Every time an ETF tracks an MSCI index, MSCI collects a small toll. It is an extremely profitable business — it keeps about 38 cents of every sales dollar as pure profit — and customers almost never leave (95 out of 100 renew every year).
The catch: the stock is expensive, and the company is growing more slowly than it used to. You pay a premium price, but sales growth has cooled from the mid-teens toward the high-single digits, and Wall Street's own price targets are basically where the stock already trades. So there is little cushion if anything goes wrong.
Our verdict is Watch — a great company we'd love to own, but only at a better price. Here's what our three scores mean in everyday terms:
Downside Risk 6/10 (a bit above average). The business itself is rock-solid, but the stock is priced high, carries real debt, and a chunk of revenue rises and falls with the stock market — so a market drop would hit it twice.
Exponential Potential 4/10 (low-to-moderate). It should keep growing steadily, but growth is slowing, not speeding up — don't expect it to double quickly.
The one big worry: roughly a quarter of the crown-jewel Index segment is "asset-based fees" that move with the size of the ETFs tracking MSCI. If markets fall, that revenue falls and investors pay a lower multiple for the stock — a double hit.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLF (sector)), set to 100 a year ago
Solid = MSCI · dashed = S&P 500 · dotted = XLF (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$603.11
Market cap$44B
P/E trailing26×
P/E FY26E / FY27E31× / 27×
EV / Sales15.5×
EV / EBITDA25.1×
Gross margin82.9%
Net margin40.7%
Dividend yield1.28%
Beta1.226
52-wk range$512 – $644
RSI(14)53
50 / 200-DMA$592 / $569
12-mo return+4% (SPY +21%)
Street target$688 ($638–$730)
Analyst grades18 Buy · 7 Hold · 1 Sell
FMP ratingC+
Next earnings2026-08-05
What the experts actually said 0 traceable claims on MSCI · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
MSCI Inc. (NYSE: MSCI) is a New-York-headquartered provider of indexes, portfolio-analytics, sustainability/climate data, and private-asset tools for the global investment community. Founded in 1998, spun out and IPO'd in 2007, it is led by founder-Chairman-CEO Henry A. Fernandez. Fiscal year ends December 31.
The economic engine is the Index segment — the MSCI-branded equity benchmarks (MSCI World, EAFE, Emerging Markets, ACWI) that asset managers license for (a) recurring subscriptions and (b) asset-based fees that scale with the AUM of ETFs and index funds linked to MSCI indexes. Around this sits Analytics (risk and performance software), Sustainability & Climate (ESG ratings and data), and Private Assets (real-estate and private-capital data). The model is overwhelmingly recurring subscription revenue with very high switching costs.
Revenue mix (FY2025, from FMP segmentation):
By product/segment: Index $1.787B (57%) · Analytics $714M (23%) · All Other (Sustainability & Climate + Private Assets) $279M+ (FMP collapses these into "All Other" for FY25; the Q1'26 release breaks Sustainability & Climate at ~11% and Private Assets at ~9% of revenue). Index is the crown jewel — highest margin (Q1'26 Index adj-EBITDA margin 75.6%) and the segment with the asset-based-fee upside/risk.
By geography: United States $1.267B (40%) · United Kingdom $543M · other EMEA $698M · Asia/Australia $841M · Japan $128M · other Americas $141M. More geographically diversified than most US large-caps, with meaningful EMEA and Asia exposure.
The strategic story management keeps pushing is "AI-fueled product innovation" — layering AI on top of its proprietary index/analytics IP — alongside expansion in private assets, wealth management, and custom/direct indexing.
2. The expert thesis (traceable)
There is no expert coverage of MSCI in the Synthos knowledge base.total_claims = 0; there are zero net-bullish voices and zero traceable claim_ids. We will not manufacture conviction we do not have.
Accordingly, this note is entirely fundamentals- and quant-driven. Every judgment below is anchored to the FMP financials, analyst estimates, the SEC 8-K earnings release, and the technical block — not to any distilled expert claim. Where the Street has a view we show it as context (consensus, grades, price targets), explicitly not as our anchor. Readers who weight this house's expert panel heavily should note that its absence here is itself information: MSCI simply has not been a subject of the investor-voices we distill.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
6 · Moderate-High
Superb economics, but 34× trailing / 25× EV/EBITDA prices in perfection; net-debt/EBITDA ~3.0× (elevated, and equity is negative from buybacks); beta 1.23; ~26% of Index revenue is asset-based fees that fall with the market — cyclicality hides inside a "stable" story.
Growth Quality
8 · High
~9% forward revenue and ~13% forward EPS CAGR, 82% gross / 55% operating margin, ROIC ~39%, 95.4% retention, a wide index moat — genuinely elite, just not fast.
Exponential Potential
4 · Low-Moderate
A toll-road compounder whose growth is decelerating (revenue +11% FY26E → +6% FY30E); no accelerating second derivative and a $44B cap cap the upside. A great business, not an exponential.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. The cases bound the range; the scores above summarize them.
Case
Key assumptions
Fair value
Bull
Markets rise (asset-based fees inflect), subscription Run Rate re-accelerates toward double digits, AI products add pricing power. FY27E EPS beats to ~$24.5 (vs $22.6 cons); premium multiple holds ~34×.
~$835 (+38%)
Base(our anchor)
Estimates roughly hit — FY27E EPS $22.6; a durable ~10–13% compounder with 82% GM earns a still-premium ~30×.
~$680 (+13%)
Bear
Equity-market drawdown cuts asset-based fees, ESG/Sustainability softness persists, retention slips; FY27E EPS misses to ~$21 and the multiple de-rates to ~22×.
~$460 (−24%)
Synthos fair value = the base case, ~$680 (+13%), with the full $460–$835 span as the honest range. This anchor sits essentially on top of the Street's $688 consensus — which is exactly why the verdict is Watch, not Buy: at today's $603 the base case offers only low-teens upside, and the Street sees no more. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). MSCI is a high-quality compounder with a decelerating growth curve — the opposite of an exponential:
Forward growth: revenue CAGR FY25→FY30E ~8.5% ($3.13B → $4.71B); EPS CAGR ~13–15% ($15.56 → $31.67) as buybacks and margin help.
Acceleration (the 2nd derivative) is negative: revenue growth +11.2% (FY26E) → +8.8% (FY27E) → +8.6% (FY28E) → +7.6% (FY29E) → +6.3% (FY30E). This is a business slowing gently, not inflecting up. Per our flagship philosophy we pick forward next-exponentials over trailing compounders — MSCI is firmly a compounder, and a maturing one.
Room to run: MSCI's TAM (global index licensing, analytics, ESG/climate, private-asset data) is large and structurally growing with passive investing, but MSCI is already the category leader; at $44B a 5× implies a ~$220B data/index company, which the growth math does not support quickly.
Reinvestment runway: modest capex (only ~1.7% of revenue), so this is a cash-return compounder — it funds a growing dividend and heavy buybacks rather than reinvesting for hyper-growth.
Exponential Potential: Low-Moderate (4/10). Own MSCI for durable ~10–13% earnings compounding plus capital return, not for a fast multibagger. The absence of an accelerating growth curve is the reason this is not a flagship exponential.
Revenue: FY25 $3.134B, +9.7% (FY24 $2.856B, +13% on FY23 $2.529B). Steady low-teens-to-high-single-digit growth; the multi-year trend is a gentle deceleration off a ~15%+ peak.
Margins: gross 82.9% TTM, operating 55.1% TTM, net 40.7% TTM. Q1'26 operating margin 53.7%, adjusted-EBITDA margin 59.3%. Among the best margin profiles in the S&P 500.
Earnings: net income $1.202B FY25 (EPS diluted $15.56, +11% on FY24 $14.05). Note the GAAP/adjusted gap: Q1'26 GAAP diluted EPS was $5.53 but included an $88M discrete tax benefit from a legal-entity restructuring; adjusted EPS was $4.55, +13.8% — the cleaner growth read.
Cash flow: operating CF $1.588B FY25, capex only −$39M, FCF $1.549B — a ~99% FCF/adjusted-net-income conversion machine. FCF yield ~3.5%.
Balance sheet (the one blemish): total debt $6.34B, net debt $5.82B, net-debt/EBITDA ~3.0× — elevated for a data company. Shareholders' equity is negative (−$2.65B) because cumulative buybacks (treasury stock −$9.8B) exceed retained earnings; this is a capital-return artifact, not distress, but it means leverage ratios and ROE are not usable in the normal way. Interest coverage ~7.7× and $1.5B FCF comfortably service the debt.
6. Valuation — priced in or room?
MSCI is not cheap on any trailing measure: 34× trailing EPS, 15.5× sales, 25× EV/EBITDA, FCF yield ~3.5%. The compounder defense is that EPS outgrows the multiple: on live consensus the forward P/E is 31× (FY26E) → 27× (FY27E) → 23× (FY28E) → 19× (FY30E) — the multiple compresses as estimates are earned, if they are earned. But the honest read is that the market already pays a premium (PEG ~1.8 trailing) for quality that is decelerating, and the leverage (~3.0× net-debt/EBITDA) is higher than the market seems to price. Street targets (context): consensus $688, high $730, low $638 — the Street's midpoint is only ~14% above the current $603, and its low is above nowhere. Our ~$680 base FV is deliberately in line with the Street here: we do not see a mispricing to exploit at $603. A quality-compounder-at-a-full-price — attractive on a pullback, not at the current quote. FMP's own quant letter rating is C+ (overall score 2/5), flagging rich P/E and stretched balance-sheet ratios — consistent with our Watch.
7. Technicals (from the tech block)
Trend: mildly up. $603 sits above the 50-DMA ($592) and 200-DMA ($569), with the 50 above the 200 (constructive posture). MACD is −5.9 (slightly negative near-term).
Location:−6.3% off the 52-week high ($643.83), +17.8% off the 52-week low ($511.84); max drawdown from peak −10.7% — mid-range, not extended.
Momentum: RSI(14) 53 — neutral, neither overbought nor oversold. No stretched-entry signal, no capitulation.
Relative strength (the tell): MSCI is +3.7% 12-mo vs SPY +20.6% and QQQ +30.3% — a pronounced laggard. It is +12.3% 3-mo (roughly matching SPY +13.7%) but well behind over 6- and 12-month windows.
Read: technicals are neutral-to-slightly-constructive but confirm that this has been a market underperformer, not a leadership name. There is no technical urgency to buy; a decline toward the 200-DMA (~$569) or lower would improve the risk/reward materially.
8. Moat & competitive position
MSCI's moat is one of the widest in financial data: (1) network-effect indexes — once an ETF ecosystem, benchmark mandates, and derivatives are built on MSCI World/EM/EAFE, switching means re-benchmarking an entire product suite, so incumbency compounds; (2) mission-critical, sticky software — 95.4% retention across Index and Analytics; (3) pricing power — recurring subscription Run Rate grows on price plus seats, and asset-based fees grow with passive AUM; (4) capital-light economics — ~1.7% capex/revenue and 82% gross margin. The chief structural vulnerability is the asset-based-fee cyclicality (fees rise and fall with equity AUM) and competition in the lower-moat ESG/Sustainability and Analytics segments.
Peer set (FMP-supplied, market cap): the closest true comp is Cboe Global Markets ($26B) and Nasdaq ($48B) among exchange/data names; the rest of the FMP peer list — JPMorgan ($896B), MetLife ($58B), Allstate ($64B), Ameriprise ($44B), AIG ($42B), SoFi ($23B), Rocket ($45B), Banco Santander Brasil ($39B) — are broad "financials" and not economically comparable to a data/index franchise. MSCI's true peer group is S&P Global, Moody's, FactSet, and MSCI itself — a small oligopoly of index/data compounders that all trade at premium multiples for the same reason: wide moats and high retention.
9. Management, capital allocation & guidance
Capital allocation: shareholder-return-first. FY25 returned $2.48B in buybacks and $557M in dividends; Q1'26 repurchased $464M (835,591 shares at avg $555.61) and declared a Q2'26 dividend of $2.05/share. The buybacks are aggressive enough to drive equity negative — appropriate given ~39% ROIC and low capex needs, but they are debt-funded at the margin (net debt rose ~$1.6B in FY25), which is the reason leverage sits at ~3.0×. Watch that the buyback pace does not push leverage higher into a market downturn.
Insider activity (a genuine positive): founder-CEO Henry Fernandez made open-market purchases on 2026-05-15 (three buys totaling 1,280 shares at ~$563–$565), on top of a ~1.73M-share stake. Open-market buying by a founder-CEO at $563 is a modestly bullish signal versus the routine director stock awards also in the file. The CFO's June sale (450 shares at $604.56) is immaterial.
Management's own guidance (half-weighted — their book): MSCI's Q1'26 earnings release (SEC 8-K, filed 2026-04-21) is a real earnings release (revenue/margins/Run Rate detail), so we summarize management's own framing, half-weighted: they reported operating revenue +14.1% ($850.8M), organic +13.3%, adjusted EPS $4.55 (+13.8%), Run Rate $3.36B (+12.7%), retention 95.4%, and record Q1 recurring net-new sales, and management (Fernandez) attributes momentum to "relentless, AI-fueled product innovation." The release provided operating detail rather than explicit full-year numeric guidance; treat the +12–14% Run Rate/organic growth as management's self-interested near-term signal, not a promise. Full-year numeric guidance was not clearly stated in the release we retrieved.
10. Catalysts & what to watch
Next earnings: 2026-07-21 (Q2'26; Street EPS $4.82, revenue ~$860M). Key lines: asset-based-fee Run Rate (the AUM-sensitive swing factor) and organic subscription Run Rate growth (currently ~8.2%).
Equity-market AUM levels: because ~26% of Index revenue is asset-based, the direction of global equity markets is a near-real-time revenue driver — a bull-case tailwind and a bear-case risk.
Subscription Run Rate re-acceleration: any move back toward double-digit organic recurring growth would justify the multiple; continued deceleration would not.
ESG/Sustainability & Climate: organic Run Rate growth there was only ~4–6.6% — watch whether the regulatory/political ESG backlash keeps pressuring this segment.
Capital allocation vs leverage: whether buybacks stay aggressive without pushing net-debt/EBITDA meaningfully above 3×.
Thesis tripwires (what would change the call): subscription Run Rate growth slipping below ~7%; retention dropping below ~94%; net-debt/EBITDA rising toward ~3.5×; or a market drawdown that cuts asset-based fees. Conversely, a de-rating toward ~25× forward on a market dip would flip this from Watch to Buy.
11. Key risks
Market cyclicality inside a "stable" story (structural): asset-based fees (~26% of Index) fall with equity AUM, so a bear market cuts revenue and the multiple simultaneously — the single biggest risk.
Valuation / de-rating: 34× trailing / 25× EV/EBITDA leaves no margin for a growth or retention disappointment; the Street's own target is ~14% above spot.
Leverage & negative equity: ~3.0× net-debt/EBITDA, debt-funded buybacks, negative book equity — fine in calm markets, less comfortable if FCF or rates move against them.
Decelerating growth: the multi-year trend is easing toward high-single-digit revenue growth; the premium multiple assumes durability the growth curve is quietly questioning.
Segment-specific softness: ESG/Sustainability & Climate growth has slowed amid political/regulatory backlash; Private Assets adjusted-EBITDA margin actually declined YoY in Q1'26.
No expert corroboration: unlike our conviction names, there is zero distilled expert coverage here — the bull case rests solely on fundamentals and quant, with no independent voices to cross-check.
12. Verdict, position sizing & monitoring
Watch. MSCI is a genuinely elite business — a network-effect index monopoly with 82% gross margins, 95% retention, ~39% ROIC, and a founder-CEO buying stock. But investing is about price, and at $603 (34× trailing, ~31× forward, EV/EBITDA 25×) the quality is fully reflected: our base-case fair value (~$680) and the Street's consensus ($688) both sit only low-teens above the quote, growth is decelerating into the high-single digits, and leverage is elevated at ~3.0×. That combination is a Watch, not a Buy — a wonderful company we want to own at a better entry.
Sizing:watch-list, not a current initiation. For investors who must own the quality, a small starter is defensible, but we would size up only on a pullback toward the 200-DMA (~$569) or a de-rating toward ~25× forward — where the risk/reward turns genuinely favorable.
Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print (next 2026-07-21). A market-driven de-rating is the most likely path from Watch to Buy.
Single biggest risk: asset-based fees ride equity-market AUM — a market drawdown would hit revenue and the multiple at the same time.
This verdict is logged as a tracked Synthos call as of 2026-07-03 at $603.11.
Provenance & disclosures
Traceability:0 KB claims, breadth 0 — MSCI has no expert coverage in the Synthos knowledge base, so this note is explicitly fundamentals- and quant-driven. No claim_ids are cited because none exist; fabricated conviction is structurally impossible (claim-ID reconciliation), and here we make none.
Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · SEC 8-K earnings release 2026-04-21. Forward figures are analyst consensus (FMP) or our own scenario model, labeled as estimates.
Management caveat: the Q1'26 earnings-release figures in §9 are management's own, self-interested words, half-weighted by design.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").